. Author manuscript; available in PMC: 2022 Nov 1.

Published in final edited form as: J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1062–e1068. doi: 10.1097/MPH.0000000000002103

Table 3:

TCD Implementation Based on Years of Eligibility with Rates of Abnormal and Conditional Results

	2012–2016
	Eligible 1+ year^b (n=5116)	Eligible 4+ years^c (n=3354)
Unique Patients who DID NOT HAVE A TCD	1461 (28.6%)	601 (17.9%)
Unique patients who only had ONE TCD	917 (17.9%)	456 (13.6%)
Unique Patients who had a TCD total	3655 (71.4%)	2753 (82.1%)
Unique Patients with abnormal TCD^a	102 (2.8%)	80 (2.9%)
Unique Patients with conditional TCD^a	495 (13.5%)	406 (14.8%)

Denominator = Unique patients who had a TCD total

Of the 5,116 patients eligible to receive a TCD for at least 1 year during the study years

Of the 3,354 patients eligible to receive a TCD for at least 4 (of the 5) years during the study years